Breast Cancer Clinical Trial

Study of Dual-energy (DE) Contrast-enhanced (CE) Digital Mammography

Summary

This is a feasibility study to evaluate dual-energy (DE) contrast-enhanced (CE) digital mammography to detect breast cancer in patients with increased breast density (BI-RADS category c or d). Eligible patients will be invited to have full-field digital mammography and dual-energy (DE) contrast-enhanced (CE) digital mammography to compare accuracy of the imaging methods for the detection of breast cancer.

View Full Description

Full Description

This is a feasibility study to evaluate dual-energy (DE) contrast-enhanced (CE) digital mammography to detect breast cancer in patients with increased breast density (Breast Imaging-Reporting And Data System category c or d). Eligible patients will be invited to have full-field digital mammography and dual-energy (DE) contrast-enhanced (CE) digital mammography to compare accuracy of the imaging methods for the detection of breast cancer

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Signed informed consent
At least 19 years old
Glomerular filtration rate> 60
Heterogeneously or extremely dense breasts (BI-RADS category c or d).

Exclusion Criteria:

History of iodinated contrast allergy
Pregnant or lactating as determined by routine standard practice
Personal history of breast cancer
History of prior breast excisional biopsy (Patients with a history of core needle biopsy will not be excluded)
History of prior breast reduction mammoplasty surgery
History of prior breast augmentation surgery
Mental condition rendering the subject unable to understand the nature, scope, and possible consequences of the study.

Study is for people with:

Breast Cancer

Estimated Enrollment:

128

Study ID:

NCT02995980

Recruitment Status:

Completed

Sponsor:

University of Alabama at Birmingham

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

The Kirklin Clinic
Birmingham Alabama, 35294, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

128

Study ID:

NCT02995980

Recruitment Status:

Completed

Sponsor:


University of Alabama at Birmingham

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider